Marcos Garcia-Lacarte1, Fermin I Milagro1,2, Maria A Zulet1,2, J Alfredo Martinez1,2, Maria L Mansego1,2. 1. a Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain. 2. b Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Carlos II Health Insitute , Madrid , Spain.
Abstract
OBJECTIVES: Epigenetic markers, and in particular DNA methylation, have come to the fore as new tools in the personalization of the treatment of obesity and its comorbidities. The objectives of the current investigation were to identify epigenetic biomarkers that might be predictive of response to a weight-loss intervention, and to better understand the influence of certain nutrients (particularly antioxidants) on the epigenome. METHODS: Global DNA (LINE-1) methylation levels were assessed in peripheral blood mononuclear cells (PBMCs) from 96 obese volunteers of the Metabolic Syndrome Reduction in Navarra study, using a methylation-sensitive high resolution melting approach after bisulfite modification. RESULTS: Baseline LINE-1 DNA methylation levels were significantly higher (5.41%) in high responders (>8% of weight loss) as compared to low responders (<8%) to the energy-restricted treatment. Indeed, a LINE-1 methylation higher than 84.15% may be predictive of a high response to the hypocaloric diet. Statistically significant correlations were found between LINE-1 baseline DNA methylation levels and the response to the treatment involving total fat mass and body weight. Furthermore, LINE-1 baseline methylation levels positively correlated with baseline dietary total antioxidant capacity (TAC). DISCUSSION: LINE-1 methylation levels in PBMCs might be used to predict response to a dietary weight-loss intervention, and seem to be related to the dietary TAC. TRIAL REGISTRATION: www.clinicaltrials.gov : NCT01087086.
OBJECTIVES: Epigenetic markers, and in particular DNA methylation, have come to the fore as new tools in the personalization of the treatment of obesity and its comorbidities. The objectives of the current investigation were to identify epigenetic biomarkers that might be predictive of response to a weight-loss intervention, and to better understand the influence of certain nutrients (particularly antioxidants) on the epigenome. METHODS: Global DNA (LINE-1) methylation levels were assessed in peripheral blood mononuclear cells (PBMCs) from 96 obese volunteers of the Metabolic Syndrome Reduction in Navarra study, using a methylation-sensitive high resolution melting approach after bisulfite modification. RESULTS: Baseline LINE-1 DNA methylation levels were significantly higher (5.41%) in high responders (>8% of weight loss) as compared to low responders (<8%) to the energy-restricted treatment. Indeed, a LINE-1 methylation higher than 84.15% may be predictive of a high response to the hypocaloric diet. Statistically significant correlations were found between LINE-1 baseline DNA methylation levels and the response to the treatment involving total fat mass and body weight. Furthermore, LINE-1 baseline methylation levels positively correlated with baseline dietary total antioxidant capacity (TAC). DISCUSSION: LINE-1 methylation levels in PBMCs might be used to predict response to a dietary weight-loss intervention, and seem to be related to the dietary TAC. TRIAL REGISTRATION: www.clinicaltrials.gov : NCT01087086.
Authors: M A Zulet; I Bondia-Pons; I Abete; R de la Iglesia; P López-Legarrea; L Forga; S Navas-Carretero; J A Martínez Journal: Nutr Hosp Date: 2011 Jan-Feb Impact factor: 1.057
Authors: Ozlem Gögebakan; Angela Kohl; Martin A Osterhoff; Marleen A van Baak; Susan A Jebb; Angeliki Papadaki; J Alfredo Martinez; Teodora Handjieva-Darlenska; Petr Hlavaty; Martin O Weickert; Claus Holst; Wim H M Saris; Arne Astrup; Andreas F H Pfeiffer Journal: Circulation Date: 2011-11-21 Impact factor: 29.690
Authors: Monica H Carlsen; Bente L Halvorsen; Kari Holte; Siv K Bøhn; Steinar Dragland; Laura Sampson; Carol Willey; Haruki Senoo; Yuko Umezono; Chiho Sanada; Ingrid Barikmo; Nega Berhe; Walter C Willett; Katherine M Phillips; David R Jacobs; Rune Blomhoff Journal: Nutr J Date: 2010-01-22 Impact factor: 3.271
Authors: Chandrika J Piyathilake; Suguna Badiga; Ronald D Alvarez; Edward E Partridge; Gary L Johanning Journal: PLoS One Date: 2013-01-24 Impact factor: 3.240
Authors: Francesca Pirini; Sebastian Rodriguez-Torres; Bola Grace Ayandibu; María Orera-Clemente; Alberto Gonzalez-de la Vega; Fahcina Lawson; Roland J Thorpe; David Sidransky; Rafael Guerrero-Preston Journal: Mol Med Rep Date: 2017-11-14 Impact factor: 2.952
Authors: Andrea Maugeri; Martina Barchitta; Roberta Magnano San Lio; Giuliana Favara; Claudia La Mastra; Maria Clara La Rosa; Antonella Agodi Journal: Dis Markers Date: 2021-12-03 Impact factor: 3.434